QCM
PRAX icon

Quantinno Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

Quantinno Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Buy
3,708
+388
+12% +$123K ﹤0.01% 2401
2026
Q1 		$1.07M Buy
3,320
+597
+22% +$185K ﹤0.01% 2098
2025
Q4 		$803K Buy
+2,723
New +$507K ﹤0.01% 1975

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Quantinno Capital Management's PRAX Position: Q2 2026 in Review

Quantinno Capital Management increased its Praxis Precision Medicines (PRAX) stake by 12% in Q2 2026, buying an estimated $123K and bringing the position to 3,708 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #2401.

Quantinno Capital Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Quantinno Capital Management held 3,708 shares of Praxis Precision Medicines worth $1.24M as of Q2 2026.
  • Quantinno Capital Management bought 388 Praxis Precision Medicines shares in Q2 2026, an estimated $123K.
  • Praxis Precision Medicines made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #2401 holding.
  • Quantinno Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.